Pfizer Moves Forward With Obesity Pill, Plans Dose Optimization Studies This ...
Pictured: Exterior view of Pfizer's office in Belgium/iStock, Alexandros Michailidis Pfizer on Thursday announced that it will move forward with its oral GLP-1 analog danuglipron, which the pharma hopes will help it carve out a niche in the …